Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of <i>Staphylococcus aureus</i> DNA Topoisomerase IV and Gyrase

Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of <i>Staphylococcus aureus</i> DNA Topoisomerase IV and Gyrase

Eleven novel imide-tetrazoles were synthesized. In the initial stage of research, in silico structure-based pharmacological prediction was conducted. All compounds were screened for antimicrobial activity using standard and clinical strains. Within the studied group, compounds <b>1</b>–&...

Full description

Bibliographic Details
Main Authors:	Piotr Roszkowski, Jolanta Szymańska-Majchrzak, Michał Koliński, Sebastian Kmiecik, Małgorzata Wrzosek, Marta Struga, Daniel Szulczyk
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	International Journal of Molecular Sciences
Subjects:	antimicrobial antibacterial tetrazole gyrase topoisomerase
Online Access:	https://www.mdpi.com/1422-0067/23/1/378

Similar Items

Actions of a Novel Bacterial Topoisomerase Inhibitor against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
by: Soziema E. Dauda, et al.
Published: (2023-07-01)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
by: Scott Grossman, et al.
Published: (2023-02-01)

Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2021-04-01)

Novel 1,2,4-oxadiazole/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity
by: Firas Obaid Arhema Frejat, et al.
Published: (2022-01-01)

A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with <i>Staphylococcus aureus</i> DNA Gyrase
by: Harry Morgan, et al.
Published: (2023-01-01)

The balance between gyrase and topoisomerase I activities determines levels of supercoiling, nucleoid compaction, and viability in bacteria
by: Míriam García-López, et al.
Published: (2023-01-01)

Synthetic Transition from Thiourea-Based Compounds to Tetrazole Derivatives: Structure and Biological Evaluation of Synthesized New <i>N</i>-(Furan-2-ylmethyl)-1<i>H</i>-tetrazol-5-amine Derivatives
by: Daniel Szulczyk, et al.
Published: (2021-01-01)

Role of the Water–Metal Ion Bridge in Quinolone Interactions with <i>Escherichia coli</i> Gyrase
by: Hannah E. Carter, et al.
Published: (2023-02-01)

Novel Bacterial Topoisomerase inhibitors (NBTIs) – A comprehensive review
by: Jigar Desai, et al.
Published: (2021-12-01)

CryoEM structures of open dimers of gyrase A in complex with DNA illuminate mechanism of strand passage
by: Katarzyna M Soczek, et al.
Published: (2018-11-01)

Synthesis of tetrazole hybridized with thiazole, thiophene or thiadiazole derivatives, molecular modelling and antimicrobial activity
by: Matokah M. Abualnaja, et al.
Published: (2024-03-01)

Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors
by: Heba E. Hashem, et al.
Published: (2020-06-01)

Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
by: Tihomir Tomašič, et al.
Published: (2021-08-01)

Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and <i>Escherichia coli</i> Topoisomerase II Inhibitors
by: Eman M. Mohi El-Deen, et al.
Published: (2020-10-01)

Fic Proteins Inhibit the Activity of Topoisomerase IV by AMPylation in Diverse Bacteria
by: Can-Hua Lu, et al.
Published: (2020-08-01)

Inhibitory action of exogenous cardiolipin on the bacterial type i and ii dna topoisomerases <i>in</i> <i>vitro</i>
by: Yu. L. Mikulovich, et al.
Published: (2012-08-01)

StaR Is a Positive Regulator of Topoisomerase I Activity Involved in Supercoiling Maintenance in <i>Streptococcus pneumoniae</i>
by: Antonio A. de Vasconcelos Junior, et al.
Published: (2023-03-01)

Determination of the Primary Molecular Target of 1,2,4-Triazole-Ciprofloxacin Hybrids
by: Tomasz Plech, et al.
Published: (2015-04-01)

The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity
by: Abdul Naeem, et al.
Published: (2016-03-01)

In silico analysis of ciprofloxacin analogs as inhibitors of DNA gyrase of Staphylococcus aureus
by: Md. Rakhibul Hasan, et al.
Published: (2021-01-01)

Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions
by: Maja Kokot, et al.
Published: (2023-05-01)

Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities
by: Temilolu Idowu, et al.
Published: (2017-11-01)

Synthesis, Characterization and Antioxidant Evaluation of Some Tetrazole Derivatives
by: Meinaa Jaber Dalal, et al.
Published: (2022-12-01)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
by: Jau-Lang Hwang, et al.
Published: (2009-03-01)

Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
by: Natassja G. Bush, et al.
Published: (2020-12-01)

Rapid Identification of Mutations in Quinolone-Resistant Shigella Isolates by Scanning of gyrA and parC Genes using High-Resolution Melting Curve Analysis
by: Mohammad Mehdi Soltan Dallal, et al.
Published: (2020-05-01)

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
by: Huanli Xu, et al.
Published: (2016-11-01)

DNA Gyrase as a Target for Quinolones
by: Angela C. Spencer, et al.
Published: (2023-01-01)

Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium
by: Jirachaya Toyting, et al.
Published: (2023-12-01)

Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation
by: Martina Durcik, et al.
Published: (2020-12-01)

Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
by: Manoj Chandran, et al.
Published: (2015-01-01)

Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro
by: Anna Chen, et al.
Published: (2022-12-01)

New Potential Pharmacological Targets of Plant-Derived Hydroxyanthraquinones from <i>Rubia</i> spp.
by: Petko Alov, et al.
Published: (2022-05-01)

A RADAR-Based Assay to Isolate Covalent DNA Complexes in Bacteria
by: Katie J. Aldred, et al.
Published: (2019-02-01)

Thiosemicarbazide Derivatives Decrease the ATPase Activity of <i>Staphylococcus aureus</i> Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in <i>Mycobacterium smegmatis</i>
by: Aleksandra Kowalczyk, et al.
Published: (2021-04-01)

Crystal Structures of the 43 kDa ATPase Domain of <i>Xanthomonas Oryzae</i> pv. <i>Oryzae</i> Topoisomerase IV ParE Subunit and its Complex with Novobiocin
by: Ha Yun Jung, et al.
Published: (2019-11-01)

Docking studies on novel analogs of quinolones against DNA gyrase of Escherichia coli
by: Cristian Davila, et al.
Published: (2018-09-01)

From the DNA Gyrase Inhibitor Cyclothialidine to a New Class of Antibacterial Agents
by: Erwin Goetschi, et al.
Published: (2003-04-01)

Bacterial Argonaute Proteins Aid Cell Division in the Presence of Topoisomerase Inhibitors in Escherichia coli
by: Anna Olina, et al.
Published: (2023-06-01)

Cytotoxicity Evaluation of Novel bis(2-aminoethyl)amine Derivatives
by: Daniel Szulczyk, et al.
Published: (2020-06-01)